Treasurer of the State of North Carolina
Position in RPRX — Royalty Pharma plc
CIK 1761054
RALEIGH, NC
Position in RPRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$26,097,263
+$6,565,323 QoQ
Shares Held
544,033
+7.6% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Treasurer of the State of North Carolina holds $227,922,242 across 22 Biotechnology names. RPRX ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,663 | $48,522,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,382 | $46,653,548 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
544,033 | $26,097,263 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,269 | $17,955,984 | |
| 5 | INSM |
INSMED Inc
|
89,647 | $14,659,077 | |
| 6 | INCY |
Incyte Corp
|
136,241 | $12,823,002 | |
| 7 | EXEL |
Exelixis, Inc.
|
276,296 | $11,850,335 | |
| 8 | MRNA |
Moderna, Inc.
|
153,407 | $7,793,075 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,097,263 | 544,033 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,531,940 | 505,485 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,120,584 | 513,622 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,938,412 | 525,629 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,251,493 | 297,189 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,389,990 | 172,089 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,174,976 | 182,926 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,098,932 | 231,283 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,341,445 | 175,879 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,909,485 | 174,777 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $4,700,539 | 173,196 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,304,309 | 172,554 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,048,320 | 167,869 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,592,686 | 166,819 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,521,977 | 162,319 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,528,349 | 155,289 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,668,304 | 119,823 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,878,955 | 122,433 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,420,030 | 122,303 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $4,639,822 | 113,194 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,129,886 | 117,604 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,002,200 | 40,004 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,314,266 | 31,240 | Shares | Sole | 2020-11-04 | |
| No filing history on record for this holder in this stock. | ||||||